Sativex Study Confirms Long Term Effectiveness In MS Neuropathic Pain September 15, 2008
Results from a new study investigating the benefits of Sativex in neuropathic pain in people with multiple sclerosis (MS) have shown it gave long-term pain relief. The study followed 42 people with MS who took Sativex – a cannabis-based drug trialled by GW Pharmaceuticals. This

add to del.icio.us
Print This Post































Leave a Reply